Extracorporeal Shock Wave Therapy in Enhancing Sensitivity and Postura
Efficacy of Extracorporeal Shock Wave Therapy in Enhancing Plantar Sensitivity and Postural Stability in Multiple Sclerosis: A Quantitative Gait and Sensory Analysis
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 20 months ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Extracorporeal Shock Wave Therapy (ESWT)
What it measured
Main measures
Static Postural Balance
From enrollment to the end of treatment at 6 weeks
Walking and mobilityPlantar Light Touch Sensitivity Threshold
From enrollment to the end of treatment at 6 weeks
Gait cycle duration
From enrollment to the end of treatment at 6 weeks
Walking and mobilityStep length
6 From enrollment to the end of treatment at 6 weeks
Walking and mobilityCadence
From enrollment to the end of treatment at 6 weeks
Walking and mobilitySingle-support time
From enrollment to the end of treatment at 6 weeks
Walking and mobilitySwing phase
From enrollment to the end of treatment at 6 weeks
Walking and mobility
Other measures (2)
Vibration Duration
From enrollment to the end of treatment at 6 weeks
Knee Position Sense
From enrollment to the end of treatment at 6 weeks
Who could take part
Relapsing MS · 18 to 65
Show the full criteria
Inclusion criteria
* Diagnosis of Multiple Sclerosis * Spasticity level below 1+ according to the Modified Ashworth Scale * Ability to walk independently or with assistive devices to perform the 3-step gait protocol * Willingness to participate in a 6-week intervention involving bilateral plantar ESWT * Stable medical condition without a recent relapse within the last 3 months
Exclusion criteria
* Presence of severe cognitive impairment that prevents following test instructions * Other neurological disorders (e.g., Parkinson's disease, polyneuropathy) that could interfere with sensory or gait assessments * Presence of open wounds, active infections, or skin integrity issues on the plantar surface of the feet * Contraindications for Extracorporeal Shock Wave Therapy
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
This randomized controlled trial aimed to investigate the efficacy of Extracorporeal Shock Wave Therapy (ESWT) on plantar somatosensory function, knee joint proprioception, and spatiotemporal gait parameters in individuals diagnosed with Multiple Sclerosis (MS). The study included participants with a spasticity level below 1+, with the intervention group receiving ESWT three times per week over a 6-week period. To evaluate sensory changes, light touch thresholds were measured at six plantar sites-the heel, medial longitudinal arch, 1st and 5th metatarsal heads, and the 1st and 5th toes-using the Semmes-Weinstein monofilament kit. Additionally, two-point discrimination was assessed at the heel, and vibration duration was measured at the metatarsal heads using a 128 Hz tuning fork. Proprioception was quantified via the active knee joint reposition test in a closed kinetic chain position, measuring the absolute angular error at a 60° target angle. Postural stability and dynamic gait were objectively analyzed using the Win-Track platform and a reliable 3-step protocol to record parameters such as gait cycle duration, step length, cadence, and maximum plantar pressure. Static balance was further evaluated by recording the percentage of body weight transferred to each foot. By targeting both mechanoreceptor sensitivity and joint position sense, this 6-week ESWT intervention seeks to enhance the overall functional mobility and stability of MS patients.
Loading reviews and guidelines…
History
Started
Jul 2021
Main results due
Feb 2025
Finished
Oct 2025